share_log

Allarity Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Streeterville Capital LLC(14.7%),Streeterville Management LLC(14.7%), etc.

SEC ·  Aug 30 04:01

Summary by Moomoo AI

Streeterville Capital LLC, along with Streeterville Management LLC and John M. Fife, have filed a Schedule 13G with the SEC, indicating a significant ownership stake in Allarity Therapeutics Inc. The filing, dated August 19, 2024, reports that Streeterville Capital LLC directly owns 8,999,800 shares of Allarity Therapeutics' common stock, representing 14.7% of the company's class of securities. John M. Fife, a U.S. citizen, is identified as the person with the authority to receive notices and communications regarding this ownership. The shares provide Streeterville Capital LLC with sole voting power and sole dispositive power over 2,114,737 shares. The filing asserts that the securities were acquired in the ordinary course of business and not with the purpose of changing or influencing the control of the issuer.
Streeterville Capital LLC, along with Streeterville Management LLC and John M. Fife, have filed a Schedule 13G with the SEC, indicating a significant ownership stake in Allarity Therapeutics Inc. The filing, dated August 19, 2024, reports that Streeterville Capital LLC directly owns 8,999,800 shares of Allarity Therapeutics' common stock, representing 14.7% of the company's class of securities. John M. Fife, a U.S. citizen, is identified as the person with the authority to receive notices and communications regarding this ownership. The shares provide Streeterville Capital LLC with sole voting power and sole dispositive power over 2,114,737 shares. The filing asserts that the securities were acquired in the ordinary course of business and not with the purpose of changing or influencing the control of the issuer.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more